VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
83 hedge funds and large institutions have $111M invested in Viracta Therapeutics, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 17 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2% less capital invested
Capital invested by funds: $113M → $111M (-$1.8M)
Holders
83
Holding in Top 10
–
Calls
$5.31M
Puts
$3.3M
Top Buyers
| 1 | +$4.29M | |
| 2 | +$3.61M | |
| 3 | +$3.19M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$2.54M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$1.48M |
Top Sellers
| 1 | -$6.05M | |
| 2 | -$3.05M | |
| 3 | -$2.1M | |
| 4 |
First Eagle Investment Management
New York
|
-$2.03M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.99M |